Urinary excretion profiles of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol: Study III. A Δ9-THC-COOH to creatinine ratio study

Forensic Science International

Volumn 137, Issue 2-3, 2003, Pages 196-202

  Fraser, Albert D ^a,b   Worth, David ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cannabinoids; Chronic use; Confirmation; Screening; Urine excretion

Indexed keywords

CANNABIS; CREATININE; TETRAHYDROCANNABINOLIC ACID;

ANAMNESIS; ARTICLE; BIOLOGICAL MONITORING; CALCULATION; CANNABIS ADDICTION; CONTROLLED STUDY; CREATININE URINE LEVEL; DEVICE; DILUTION; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; SCREENING; URINALYSIS; URINARY EXCRETION;

EID: 0242509870     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2003.07.011     Document Type: Article

References (13)

1. Fraser A.D. Urine drug testing for social service agencies: a Canadian experience. Clin. Lab. Med. 18:1988;705-711.
2. Fraser A.D. A six year experience with urine drug testing by family service agencies in Nova Scotia, Canada. Forensic Sci. Int. 121:2001;151-156.
3. 9-THC-COOH to creatinine ratio study. J. Anal. Toxicol. 23:1999;531-535.
4. Mule S.J., Casella G.A. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC-MS in urine following immunoassay screening. J. Anal. Toxicol. 12:1988;102-110.
5. Lafolie P., Beck O., Blennow G. Importance of creatinine analysis of urine when screening for abused drugs. Clin. Chem. 37:1991;1927-1933.
6. Preston K.L., Silverman K., Schuster C.R., Cone E.J. Comparison of self-reported drug use with quantitative and qualitative urinalysis of drug use in treatment studies. Natl. Inst. Drug Abuse Monogr. 167:1997;130-145.
7. 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J. Anal. Toxicol. 20:1996;441-452.
8. Huestis M.A., Mitchell J.M., Cone E.J. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J. Anal. Toxicol. 19:1995;443-449.
9. Huestis M.A., Cone E.J. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J. Anal. Toxicol. 22:1998;445-454.
10. J.E. Manno, K.E. Ferslew, B.R. Manno, Urine excretion patterns of cannabinoids and the clinical application of the EMIT® dau™ cannabinoid urine assay for substance abuse treatment, in: S. Agurell, W.L. Dewey, R. Willette (Eds.), The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects, Academic Press, New York, 1984, pp. 281-290.
11. 9-THC-COOH to creatinine ratio study. J. Anal. Toxicol. 23:1999;531-534.
12. 9-THC-COOH to creatinine ratio study no. 2. Forensic Sci. Int. 133:2003;26-31.
13. 9-tetrahydrocannabinol-9- carboxylic acid. J. Anal. Toxicol. 25:2001;538-548.